4-DAY CE Conference - LAS VEGAS, NV - December 09-12, 2024

1,097
Package Price 830.00

Enhance your expertise with this dynamic 4-day, knowledge-building program. Plus, you’ll be able to apply everything you learn immediately in your practice.      
 

Location:  MGM Grand Hotel & Casino       
3799 Las Vegas Boulevard South       
Las Vegas, NV 89109         

Discounted Hotel Sleeping Room Booking LINK

 

Conference Dates: December 09-12, 2024    

4-Day CE Conference Includes:   

 

Days 1 & 2:  Pharmacology Update                      
Schedule: 8 AM – 4 PM (includes breaks)                               
Contact Hours: 12 (12 Rx)                            
Presenter: Dr. Wendy Wright

Dr. Wright presents recent pharmacology updates that you can immediately implement in your practice. Get the latest guidance on myriad important topics for your practice!  

  • New Treatments in CKD 
  • New Drug Update: Focus on newer biologics, gene therapies, weight loss, new OTCs, new warnings and more 
  • Diabetes 
  • Immunization Update 
  • HTN 
  • Lipid disorder 
  • Asthma 
  • Insomnia

 

Days 3:  8-hour DEA Registration and Controlled Substance Prescribing                     
Schedule: 8 AM – 5:30 PM (includes breaks)                               
Contact Hours: 8 (8 Rx)                            
Presenter: Dr. Sally Miller

Controlled Substance Prescribing meets the 8-hour federal requirement to renew DEA registration as of 6/27/23 as mandated by Section 1262 of the Consolidated Appropriations Act, 2023. 


This 8-hour program meets the requirements of the Consolidated Appropriations Act, 2023, which requires that effective June 27, 2023 all prescribers of controlled substances must have a minimum of 8 hours of continuing education in the assessment and management of opioid or other substance use disorder in order to apply for or renew DEA registration. The program includes principles of pain management, opioid prescribing, opioid risk assessment, legislative issues, and management of opioid-use disorder with medically assisted therapy. Additionally, the program presents non-opioid controlled substance considerations, including psychostimulants, benzodiazepines, appetite suppressants, and sedative hypnotics. Indications, selection, and both assessment and management of use disorders is presented. Successful completion of this program complies with eligibility requirements for initial and renewal DEA registration, and meets most state-mandated requirements for opioid prescribing.      

Objectives: 

  • Describe the key steps in pain reception and perception. 
  • Compare and contrast mechanisms of opiate and non-opiate pain agents.
  • Discuss CDC recommendations and legislative considerations in opioid prescribing.
  • Analyze elements of opioid risk assessment.
  • Evaluate indications for and elements of medically assisted therapy.
  • Analyze indications for benzodiazepine therapy and strategies to minimize abuse potential.
  • Evaluate mechanisms and abuse potential of psychostimulants.
  • Compare and contrast controlled and non-controlled options for insomnia.

 

Days 4:  Dermatology Course                  
Schedule: 8 AM – 4 PM (includes breaks)                               
Contact Hours: 6 (0 Rx)                            
Presenter: Dr. Margaret Bobonich

This Live Dermatology CE program concentrates on the the diagnosis and therapeutic management of skin diseases'. The goal is to enhance your ability to synthesize and integrate new knowledge to formulate management approaches for patient care.  

More details to come.

 

Note: To receive a certificate of completion, each course requires attendance.